English  |  正體中文  |  简体中文  |  Total items :2822924  
Visitors :  30042257    Online Users :  1042
Project Commissioned by the Ministry of Education
Project Executed by National Taiwan University Library
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
About TAIR

Browse By

News

Copyright

Related Links

"pei jer chen"

Return to Browse by Author
Sorting by Title Sort by Date

Showing items 586-610 of 883  (36 Page(s) Totally)
<< < 19 20 21 22 23 24 25 26 27 28 > >>
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2021-07-03T03:33:49Z Addition of ribavirin to daclatasvir plus asunaprevir for chronic hepatitis C 1b patients with baseline NS5A resistance-associated variants improved response Hong C.-M.; Liu C.-J.; Yeh S.-H.; PEI-JER CHEN
臺大學術典藏 2021-07-03T03:33:49Z Corrigendum to “Signal transducer and activator of transcription 3 is a major kinase-independent target of sorafenib in hepatocellular carcinoma” (Journal of Hepatology (2011) 55(5) (1041–1048)(S0168827811001917)(10.1016/j.jhep.2011.01.047)) Tai W.-T.; Cheng A.-L.; Shiau C.-W.; Huang H.-P.; Huang J.-W.; PEI-JER CHEN; Chen K.-F.
臺大學術典藏 2021-07-03T03:33:49Z Genome-wide identification of blood DNA methylation patterns associated with early-onset hepatocellular carcinoma development in hepatitis B carriers Kao W.-Y.; Yang S.-H.; Liu W.-J.; Yeh M.-Y.; Lin C.-L.; Liu C.-J.; Huang C.-J.; Lin S.-M.; Lee S.-D.; PEI-JER CHEN; Yu M.-W.
臺大學術典藏 2021-07-03T03:33:48Z A phase I/II multicenter study of single-agent foretinib as first-line therapy in patients with advanced hepatocellular carcinoma Yau T.C.C.; Lencioni R.; Sukeepaisarnjaroen W.; Chao Y.; Yen C.-J.; Lausoontornsiri W.; PEI-JER CHEN; Sanpajit T.; Camp A.; Cox D.S.; Gagnon R.C.; Liu Y.; Raffensperger K.E.; Kulkarni D.A.; Kallender H.; Ottesen L.H.; Poon R.T.P.; Bottaro D.P.
臺大學術典藏 2021-07-03T03:33:48Z De novo assembly of highly polymorphic metagenomic data using in situ generated reference sequences and a novel BLAST-based assembly pipeline Lin Y.-Y.; Hsieh C.-H.; Chen J.-H.; Lu X.; Kao J.-H.; PEI-JER CHEN; Chen D.-S.; Wang H.-Y.
臺大學術典藏 2021-07-03T03:33:48Z Prescription patterns of sorafenib and outcomes of patients with advanced hepatocellular carcinoma: A national population study Lu L.-C.; PEI-JER CHEN; Yeh Y.-C.; Hsu C.-H.; Chen H.-M.; Lai M.-S.; Shao Y.-Y.; Cheng A.-L.
臺大學術典藏 2021-07-03T03:33:47Z Corrigendum to “Signal transducer and activator of transcription 3 is a major kinase-independent target of sorafenib in hepatocellular carcinoma” (Journal of Hepatology (2017) 66(3) (666–668) (S0168827816307127) (10.1016/j.jhep.2016.12.007)) Tai W.-T.; Cheng A.-L.; Shiau C.-W.; Huang H.-P.; Huang J.-W.; PEI-JER CHEN; Chen K.-F.
臺大學術典藏 2021-07-03T03:33:47Z Chronologic changes in serum hepatitis B virus DNA, genotypes, surface antigen mutants and reverse transcriptase mutants during 25-year nationwide immunization in Taiwan Hsu H.-Y.; Chang M.-H.; Ni Y.-H.; Chiang C.-L.; Wu J.-F.; Chen H.-L.; PEI-JER CHEN; Chen D.-S.
臺大學術典藏 2021-07-03T03:33:47Z Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update Omata M.; Cheng A.-L.; Kokudo N.; Kudo M.; Lee J.M.; Jia J.; Tateishi R.; Han K.-H.; Chawla Y.K.; Shiina S.; Jafri W.; Payawal D.A.; Ohki T.; Ogasawara S.; PEI-JER CHEN; Lesmana C.R.A.; Lesmana L.A.; Gani R.A.; Obi S.; Dokmeci A.K.; Sarin S.K.
臺大學術典藏 2021-07-03T03:33:47Z Peg-interferon lambda treatment induces robust innate and adaptive immunity in chronic hepatitis B patients Phillips S.; Mistry S.; Riva A.; Cooksley H.; Hadzhiolova-Lebeau T.; Plavova S.; Katzarov K.; Simonova M.; Zeuzem S.; Woffendin C.; PEI-JER CHEN; Peng C.-Y.; Chang T.-T.; Lueth S.; Knegt R.D.; Choi M.-S.; Wedemeyer H.; Dao M.; Kim C.-W.; Chu H.-C.; Wind-Rotolo M.; Williams R.; Cooney E.; Chokshi S.
臺大學術典藏 2021-07-03T03:33:46Z Fibrosis-4 Index Helps Identify HBV Carriers with the Lowest Risk of Hepatocellular Carcinoma Tseng T.-C.; Liu C.-J.; Su T.-H.; Yang W.-T.; Chen C.-L.; Yang H.-C.; Wang C.-C.; Kuo S.F.-T.; Liu C.-H.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-07-03T03:33:46Z Impact of occult hepatitis B on the clinical outcomes of patients with chronic hepatitis C virus infection: A 10-year follow-up Chen H.-Y.; Su T.-H.; Tseng T.-C.; Yang W.-T.; Chen T.-C.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.; Liu C.-J.
臺大學術典藏 2021-07-03T03:33:45Z The present and future disease burden of hepatitis C virus infections with today's treatment paradigm: Volume 4 Chan H.L.Y.; Chen C.J.; Omede O.; Al Qamish J.; Al Naamani K.; Bane A.; Tan S.S.; Simonova M.; Cardenas I.; Derbala M.; Akin O.; Phillips R.O.; Abdelmageed M.K.; Abdulla M.; Adda D.; Al Baqali A.; Al Dweik N.; Al Ejji K.; Al ghazzawi I.; Al Kaabi S.; Al Sadadi M.; Al Salman J.; AlBadri M.; Al-Busafi S.A.; Al-Romaihi H.E.; Ampofo W.; Antonov K.; Anyaike C.; Arome F.; Blach S.; Borodo M.M.; Brandon S.M.; Bright B.; Butt M.T.; Chen D.S.; PEI-JER CHEN; Chien R.N.; Chuang W.L.; Cuellar D.; Elbardiny A.A.; Estes C.; Farag E.; Fung J.; Gamkrelidze I.; Garcia V.; Genov J.; Ghandour Z.; Ghuloom M.; Gomez B.; Gunter J.; Habeeb J.; Hajelssedig O.; Hamoudi W.; Himatt S.M.; Hrstic I.; Hu C.C.; Huang C.F.; Hui Y.T.; Jahis R.; Jelev D.; John A.K.; Kaliaskarova K.S.; Kamel Y.; Kao J.H.; Khamis J.; Khattabi H.; Khoudri I.; Konysbekova A.; Kotzev I.; Lai M.S.; Lao W.C.; Layden J.; Lee M.H.; Lesi O.; Li M.; Lo A.; Loo C.K.; Luk?i? B.; Maaroufi A.; Malu A.O.; Mateva L.; Mitova R.; Mohamed R.; Morovi? M.; Murphy K.; Mustapha B.; Nersesov A.; Ngige E.; Njouom R.; Njoya O.; Nonkovi? D.; Obekpa S.; Oguche S.; Okolo E.E.; Omuemu C.; Ondoa P.; Opare-Sem O.; Owusu-Ofori S.; Prokopenko Y.N.; Razavi H.; Razavi-Shearer D.; Razavi-Shearer K.; Redae B.; Reic T.; Rinke de Wit T.; Rios C.; Robbins S.; Roberts L.R.; Sanad S.J.; Schmelzer J.D.; Sharma M.; Su T.H.; Sultan K.; Tchernev K.; Tsang O.T.Y.; Tsang S.; Tzeuton C.; Ugoeze S.; Uzochukwu B.; Vi R.; Vince A.; Wani H.U.; Wong V.W.S.; Workneh A.; Yacoub R.; Yesmembetov K.I.; Youbi M.; Yuen M.F.; Nde H.
臺大學術典藏 2021-07-03T03:33:45Z Strategies to manage hepatitis C virus infection disease burden—Volume 4 Chen D.S.; Hamoudi W.; Mustapha B.; Layden J.; Nersesov A.; Reic T.; Garcia V.; Rios C.; Mateva L.; Njoya O.; Al-Busafi S.A.; Abdelmageed M.K.; Abdulla M.; Adda D.; Akin O.; Al Baqali A.; Al Dweik N.; Al Ejji K.; Al ghazzawi I.; Al Kaabi S.; Al Naamani K.; Al Qamish J.; Al Sadadi M.; Al Salman J.; AlBadri M.; Al-Romaihi H.E.; Ampofo W.; Antonov K.; Anyaike C.; Arome F.; Bane A.; Blach S.; Borodo M.M.; Brandon S.M.; Bright B.; Butt M.T.; Cardenas I.; Chan H.L.Y.; Chen C.J.; PEI-JER CHEN; Chien R.N.; Chuang W.L.; Cuellar D.; Derbala M.; Elbardiny A.A.; Estes C.; Farag E.; Fung J.; Gamkrelidze I.; Genov J.; Ghandour Z.; Ghuloom M.; Gomez B.; Gunter J.; Habeeb J.; Hajelssedig O.; Himatt S.M.; Hrstic I.; Hu C.C.; Huang C.F.; Hui Y.T.; Jahis R.; Jelev D.; John A.K.; Kaliaskarova K.S.; Kamel Y.; Kao J.H.; Khamis J.; Khattabi H.; Khoudri I.; Konysbekova A.; Kotzev I.; Lai M.S.; Lao W.C.; Lee M.H.; Lesi O.; Li M.; Lo A.; Loo C.K.; Luk?i? B.; Maaroufi A.; Malu A.O.; Mitova R.; Mohamed R.; Morovi? M.; Murphy K.; Nde H.; Ngige E.; Njouom R.; Nonkovi? D.; Obekpa S.; Oguche S.; Okolo E.E.; Omede O.; Omuemu C.; Ondoa P.; Opare-Sem O.; Owusu-Ofori S.; Phillips R.O.; Prokopenko Y.N.; Razavi H.; Razavi-Shearer D.; Razavi-Shearer K.; Redae B.; Rinke de Wit T.; Robbins S.; Roberts L.R.; Sanad S.J.; Sharma M.; Simonova M.; Su T.H.; Sultan K.; Tan S.S.; Tchernev K.; Tsang O.T.Y.; Tsang S.; Tzeuton C.; Ugoeze S.; Uzochukwu B.; Vi R.; Vince A.; Wani H.U.; Wong V.W.S.; Workneh A.; Yacoub R.; Yesmembetov K.I.; Youbi M.; Yuen M.F.; Schmelzer J.D.
臺大學術典藏 2021-07-03T03:33:44Z Genome-wide association analysis identifies a GLUL haplotype for familial hepatitis B virus-related hepatocellular carcinoma Lin Y.-Y.; Yu M.-W.; Lin S.-M.; Lee S.-D.; Chen C.-L.; Chen D.-S.; PEI-JER CHEN
臺大學術典藏 2021-07-03T03:33:44Z Historical epidemiology of hepatitis C virus in select countries—volume 4 Maaroufi A.; Vince A.; Himatt S.M.; Mohamed R.; Fung J.; Opare-Sem O.; Workneh A.; Njouom R.; Al ghazzawi I.; Abdulla M.; Kaliaskarova K.S.; Owusu-Ofori S.; Abdelmageed M.K.; Adda D.; Akin O.; Al Baqali A.; Al Dweik N.; Al Ejji K.; Al Kaabi S.; Al Naamani K.; Al Qamish J.; Al Sadadi M.; Al Salman J.; AlBadri M.; Al-Busafi S.A.; Al-Romaihi H.E.; Ampofo W.; Antonov K.; Anyaike C.; Arome F.; Bane A.; Blach S.; Borodo M.M.; Brandon S.M.; Bright B.; Butt M.T.; Cardenas I.; Chan H.L.Y.; Chen C.J.; Chen D.S.; PEI-JER CHEN; Chien R.N.; Chuang W.L.; Cuellar D.; Derbala M.; Elbardiny A.A.; Estes C.; Farag E.; Gamkrelidze I.; Garcia V.; Genov J.; Ghandour Z.; Ghuloom M.; Gomez B.; Gunter J.; Habeeb J.; Hajelssedig O.; Hamoudi W.; Hrstic I.; Hu C.C.; Huang C.F.; Hui Y.T.; Jahis R.; Jelev D.; John A.K.; Kamel Y.; Kao J.H.; Khamis J.; Khattabi H.; Khoudri I.; Konysbekova A.; Kotzev I.; Lai M.S.; Lao W.C.; Layden J.; Lee M.H.; Lesi O.; Li M.; Lo A.; Loo C.K.; Luk?i? B.; Malu A.O.; Mateva L.; Mitova R.; Morovi? M.; Murphy K.; Mustapha B.; Nde H.; Nersesov A.; Ngige E.; Njoya O.; Nonkovi? D.; Obekpa S.; Oguche S.; Okolo E.E.; Omede O.; Omuemu C.; Ondoa P.; Phillips R.O.; Prokopenko Y.N.; Razavi H.; Razavi-Shearer D.; Redae B.; Reic T.; Rinke de Wit T.; Rios C.; Robbins S.; Roberts L.R.; Sanad S.J.; Schmelzer J.D.; Sharma M.; Simonova M.; Su T.H.; Sultan K.; Tan S.S.; Tchernev K.; Tsang O.T.Y.; Tsang S.; Tzeuton C.; Ugoeze S.; Uzochukwu B.; Vi R.; Wani H.U.; Wong V.W.S.; Yacoub R.; Yesmembetov K.I.; Youbi M.; Yuen M.F.; Razavi-Shearer K.
臺大學術典藏 2021-07-03T03:33:43Z Src-homology protein tyrosine phosphatase-1 agonist, SC-43, reduces liver fibrosis Su T.-H.; Shiau C.-W.; Jao P.; Yang N.-J.; Tai W.-T.; Liu C.-J.; Tseng T.-C.; Yang H.-C.; Liu C.-H.; Huang K.-W.; Hu T.-C.; Huang Y.-J.; Wu Y.-M.; Chen L.-J.; PEI-JER CHEN; Chen D.-S.; Chen K.-F.; Kao J.-H.
臺大學術典藏 2021-07-03T03:33:43Z Hepatitis B virus reactivation in patients receiving interferon-free direct-acting antiviral agents for chronic hepatitis C virus infection Liu C.-H.; Liu C.-J.; Su T.-H.; Fang Y.-J.; Yang H.-C.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-07-03T03:33:42Z A noninvasive diagnosis of hepatic fibrosis by BioFibroScore? in chronic hepatitis C patients Liu C.-H.; Liu C.-J.; Hong C.-M.; Su T.-H.; Yang H.-C.; Chen K.-M.; Huang Y.-P.; Yeh Y.-M.; Tien H.-L.; Liu Y.-C.; Kao J.-H.; Chen D.-S.; PEI-JER CHEN
臺大學術典藏 2021-07-03T03:33:42Z Intracellular hepatitis B virus increases hepatic cholesterol deposition in alcoholic fatty liver via hepatitis B core protein Wang Y.; Wu T.; Hu D.; Weng X.; Wang X.; PEI-JER CHEN; Luo X.; Wang H.; Ning Q.
臺大學術典藏 2021-07-03T03:33:42Z Corrigendum to “Blockade of STAT3 activation by sorafenib derivatives through enhancing SHP-1 phosphatase activity” (Eur. J. Med. Chem. (2012) 55 (220–227)(S0223523412004497)(10.1016/j.ejmech.2012.07.023)) Chen K.-F.; Tai W.-T.; Hsu C.-Y.; Huang J.-W.; Liu C.-Y.; PEI-JER CHEN; Kim I.; Shiau C.-W.
臺大學術典藏 2021-07-03T03:33:42Z Exploring new therapies for a serological cure of chronic hepatitis B Horng J.-H.; Wu C.-R.; PEI-JER CHEN
臺大學術典藏 2021-07-03T03:33:41Z The potential and challenges of CRISPR-Cas in eradication of hepatitis B virus covalently closed circular DNA Yang H.-C.; PEI-JER CHEN
臺大學術典藏 2021-07-03T03:33:41Z Research priorities for the discovery of a cure for chronic hepatitis B: Report of a workshop Block T.M.; Alter H.; Brown N.; Brownstein A.; Brosgart C.; Chang K.-M.; PEI-JER CHEN; Cohen C.; El-Serag H.; Feld J.; Gish R.; Glenn J.; Greten T.F.; Guo J.-T.; Hoshida Y.; Kowdley K.V.; Li W.; Lok A.S.; McMahon B.; Mehta A.; Perrillo R.; Rice C.M.; Rinaudo J.; Schinazi R.F.; Shetty K.
臺大學術典藏 2021-07-03T03:33:41Z Sofosbuvir-based Interferon-Free Direct Acting Antiviral Regimens for Heart Transplant Recipients with Chronic Hepatitis C Virus Infection Liu C.-H.; Chen Y.-S.; Wang S.-S.; Liu C.-J.; Su T.-H.; Yang H.-C.; Hong C.-M.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.

Showing items 586-610 of 883  (36 Page(s) Totally)
<< < 19 20 21 22 23 24 25 26 27 28 > >>
View [10|25|50] records per page